TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | -9 | 3 | 0 | 0 | 0 | -3 |
| P | %wins | 100 | 0 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/18 18:09 | 10/26/18 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Fyfe Gwen A. | CO | D | M.d | 0 | 0.00 | 0 | 5 | 50 | 15 | D | |||||||||||||||
10/27/17 16:28 | 10/27/17 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Fyfe Gwen A. | CO | D | M.d | 52 | 10.47 | 0 | 5 | 100 | 10 | D | |||||||||||||||
6/27/17 17:38 | 6/24/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Fyfe Gwen A. | WA | D | M.d | 0 | 0.00 | 0 | 9 | 849 | 10 | D | |||||||||||||||
3/30/17 18:34 | 3/28/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Fyfe Gwen A. | WA | D | P | 7 | 4.12 | 1 | 2 | 100 | 3 | D | -59 | -41 | -58 | -11 | -4 | 0 | 6 | 2 | 0 | -9 | 3 | ||||
10/31/16 19:15 | 10/29/16 | ARRY | Array Biopharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Fyfe Gwen A. | CO | D | M.d | 29 | 5.83 | 27 | 5 | New | 5 | D | 53 | 14 | 76 | 38 | 58 | -14 | -6 | -4 | 7 | 3 | 43 | 89 | 28 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |